Novo Nordisk A/S (NVO) Reports Positive Results From First Phase 3 Trial With Long-Acting Factor IX for Treatment of Hemophilia B
5/17/2013
More...
|
Safety Results From Auris Medical AG's Clinical Development of AM-101 Presented at International Conference
5/17/2013
More...
|
Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-Resistant Epilepsy
5/17/2013
More...
|
A*STAR and Cytos Biotechnology AG Bring Singapore's First Influenza Vaccine to Clinical Testing
5/17/2013
More...
|
AREVA Med LLC Med Presents Pharmacokinetics Data From Phase 1 Clinical Trial at SNMMI
5/17/2013
More...
|
Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis
5/17/2013
More...
|
Oramed Pharmaceuticals Inc. (ORMP.OB) Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S.
5/17/2013
More...
|
Alnylam Pharmaceuticals (ALNY) Presents Key Pre-Clinical Proof-of-Concept Data for ALN-AS1, an RNAi Therapeutic Targeting Aminolevulinate Synthase-1 (ALAS-1) for the Treatment of Porphyria
5/17/2013
More...
|
UCB, Inc. (UCBJF.PK) Release: New Study Shows Effect of Neupro® (Rotigotine Transdermal System) on Cardiovascular Measures in Patients with Restless Legs Syndrome
5/17/2013
More...
|
Mylan Inc. (MYL) Launches Generic Tricor® Tablets
5/17/2013
More...
|
Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color
5/17/2013
More...
|
XenoPort, Inc. (XNPT) Provides Update on Availability of Horizant
5/17/2013
More...
|
IMPAX Laboratories, Inc. (IPXL) Launches Authorized Generic of Zomig (zolmitriptan) Tablets and Orally Disintegrating Tablets in the U.S.
5/17/2013
More...
|
Pearl Therapeutics Presents Dose-Ranging, Efficacy and Safety Results of PT003 as well as Components, PT001 and PT005 at American Thoracic Society Meeting
5/17/2013
More...
|
Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice, Magceutics Reveals
5/16/2013
More...
|